Rosalind-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
34
Total Value
205636842
Accession Number
0001622627-25-000027
Form Type
13F-HR
Manager Name
Rosalind-Advisors
Data Enrichment
79% identified
27 identified7 unidentified

Holdings

34 positions • $205.6M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
DELCATH SYSTEMS, INC.
Shares:2.9M
Value:$29.0M
% of Portfolio:14.1% ($29.0M/$205.6M)
Verastem, Inc.
Shares:2.6M
Value:$15.9M
% of Portfolio:7.8% ($15.9M/$205.6M)
Xeris Biopharma Holdings, Inc.
Shares:2.5M
Value:$13.7M
% of Portfolio:6.7% ($13.7M/$205.6M)
MYOMO, INC.
Shares:2.7M
Value:$13.0M
% of Portfolio:6.3% ($13.0M/$205.6M)
IDEAYA Biosciences, Inc.
Shares:700.0K
Value:$11.5M
% of Portfolio:5.6% ($11.5M/$205.6M)
FENNEC PHARMACEUTICALS INC.
Shares:1.8M
Value:$10.9M
% of Portfolio:5.3% ($10.9M/$205.6M)
UroGen Pharma Ltd.
Shares:950.0K
Value:$10.5M
% of Portfolio:5.1% ($10.5M/$205.6M)
OCULAR THERAPEUTIX, INC
Shares:1.2M
Value:$8.9M
% of Portfolio:4.3% ($8.9M/$205.6M)
ABEONA THERAPEUTICS INC.
Shares:1.8M
Value:$8.6M
% of Portfolio:4.2% ($8.6M/$205.6M)
Replimune Group, Inc.
Shares:850.0K
Value:$8.3M
% of Portfolio:4.0% ($8.3M/$205.6M)
Viridian Therapeutics, Inc.\DE
Shares:595.0K
Value:$8.0M
% of Portfolio:3.9% ($8.0M/$205.6M)
MediWound Ltd.
Shares:506.9K
Value:$7.9M
% of Portfolio:3.8% ($7.9M/$205.6M)
Savara Inc
Shares:2.7M
Value:$7.4M
% of Portfolio:3.6% ($7.4M/$205.6M)
Verona Pharma plc
Shares:100.0K
Value:$6.3M
% of Portfolio:3.1% ($6.3M/$205.6M)
45779A846
Shares:2.3M
Value:$6.1M
% of Portfolio:3.0% ($6.1M/$205.6M)
CYBIN INC.
Shares:810.9K
Value:$5.1M
% of Portfolio:2.5% ($5.1M/$205.6M)
Nuvation Bio Inc.
Shares:2.5M
Value:$4.3M
% of Portfolio:2.1% ($4.3M/$205.6M)
Profound Medical Corp.
Shares:692.2K
Value:$4.0M
% of Portfolio:2.0% ($4.0M/$205.6M)
Trevi Therapeutics, Inc.
Shares:612.9K
Value:$3.9M
% of Portfolio:1.9% ($3.9M/$205.6M)
Pharvaris N.V.
Shares:223.6K
Value:$3.5M
% of Portfolio:1.7% ($3.5M/$205.6M)